Benjamin Edwards’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Benjamin Edwards's VRTX Position: Q3 2026 in Review
Benjamin Edwards increased its Vertex Pharmaceuticals (VRTX) stake by 18% in Q3 2026, buying an estimated $1.04M and bringing the position to 13,052 shares worth $6.83M. The position accounts for 0.06% of the portfolio, ranked #298.
Benjamin Edwards first reported a position in VRTX in Q3 2021 and has held it in 14 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Benjamin Edwards held 13,052 shares of Vertex Pharmaceuticals worth $6.83M as of Q3 2026.
- Benjamin Edwards bought 2,027 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.04M.
- Vertex Pharmaceuticals made up 0.06% of Benjamin Edwards's portfolio in Q3 2026, its #298 holding.
- Benjamin Edwards first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.